Rylo Health review

Take a quarter dose here and you pay the full-dose rate — Rylo puts it in writing and then illustrates it, with a table showing the dose climbing over three months and the figure standing still. That is exactly the reassurance a reader who expects to titrate upward wants, and exactly the wrong shape for someone taking less to spend less. Give it credit for printing the standard rate next to the promotional one on every card, which is where most of this category hides the step-up. Two things will cost you if you misread them. The promotional rate is limited to twenty members and described as locked for life, but the counter tracking those places is fixed in the page and never moves, so treat the urgency as decoration. And the worked example uses one molecule's doses against the other molecule's price, so do not read it as the rate for the drug it names.

Vs median

$26/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Rylo Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Rylo Health sells compounded semaglutide and compounded tirzepatide as a monthly membership with no membership fee on top, at rates printed openly on its homepage alongside a promotional "First 20" tier. It says it works directly with a single compounding pharmacy and prices accordingly, though it never names that pharmacy. It also sells NAD+, sermorelin and glutathione, and lists several other peptides as coming soon. It says it prescribes in all 50 states through US-licensed physicians, with same-day review. The operating entity is Rylo Health LLC.

ONE FLAT RATE AT EVERY DOSE. A patient deliberately holding a quarter dose pays the same $149 as one at the top of the range

• THE SCARCITY COUNTER DOES NOT MOVE. "12 of 20 spots have been filled" is baked into the page and does not change, so the deadline behind the "First 20" rate that is "locked monthly for life" is decorative
• Its own flat-price illustration shows tirzepatide doses — 2.5 mg, 5.0 mg, 7.5 mg — against $149, which is the semaglutide rate; tirzepatide's own standard rate is $249
• The "no middlemen, ever" claim rests entirely on a direct relationship with a compounding pharmacy that is never named anywhere on the site
• No week count is published, so whether a monthly charge ships four weeks or a calendar month of medication is unknown
• Pricing lives only on the homepage; the individual medication pages carry none of their own
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Rylo Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan